Company
LIfT Biosciences
Re-arming the innate immune system against solid tumours
Also known as LIFT BioSciences Ltd
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- London, United Kingdom
- Founded
- 2016
- Legal name
- LIFT BioSciences Ltd
- liftbiosciences.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
LIFT BioSciences is pioneering a new class of immunotherapy for hard-to-treat cancers based on allogeneic Immuno-Modulatory Alpha Neutrophils (IMANs)®. Our proprietary, platform harnesses neutrophils’ innate tumour-homing and infiltrating attributes, combined with their ability to directly kill cancer cells and safely orchestrate broader immune responses, offering a powerful and antigen-independent treatment option to overcome cancer resistance mechanisms, like suppressive tumour environment and immune evasion.
Funding snapshot
- Latest round
- Grant2025-07-29
Funding rounds
- Grant
- 2025-07-29
Products
- Other
- Immunomodulatory Alpha Neutrophils (IMANs)
Loading relationship preview